Delivery Order SPE2DB20D7059-SPE2DB25FQNF0
Award Date 8/12/25
Potential Completion Date 8/13/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,044.82 to supply Micardis HCT 80-25 mg tablet unit dose packages (30 count) with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $3,631.02 to AmerisourceBergen Drug Corp for the supply of Micardis HCT 40-12.5 mg tablets in unit dose packaging (30 count) on August 11, 2025, with completion due by August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen Drug Corp's larger prime indefinite delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,217.60, is for the supply of MICARDIS HCT 80-25 mg tablet units with an ultimate completion date of March 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,556.28 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,436.94 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product, with a completion date of February 6, 2024. This delivery order contract is issued under a larger, single-award indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $4,262.73 to AmerisourceBergen Drug Corp for the supply of Micardis HCT 80-25 mg tablets (30-count unit dose packaging). This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The contract leverages AmerisourceBergen's established pharmaceutical supply relationship with the federal government, with performance occurring at the company's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,037.48 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S. This delivery order is a part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued up to $999,999,999.00 and with a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $1,989.04 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. This order, which does not have a set-aside designation, is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a brand name pharmaceutical product. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,493.15, is for the delivery of Micardis HCT 40-12.5 mg tablets. The delivery order has an ultimate completion date of June 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
- The Defense Logistics Agency awarded a delivery order valued at approximately $333 to Amerisourcebergen Drug Corporation for the supply of 80-25 mg tablets of Micardis HCT. As the prime contractor, Amerisourcebergen will deliver 30 units of the medication to a facility located in Conshohocken, Pennsylvania by June 23, 2023. Pricing is firm fixed. The order was placed under an existing DLA contract vehicle, though details of that contract were not provided. As a major supplier of...